$EOLS Evolus, Inc. Insider Trading
Get free email notifications about insider trading in Evolus, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Evolus, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Evolus, Inc. for free.
CIK Number: 0001570562
IRS Number: 461385614
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EOLS
Company Address: 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH 92660
Phone number: 9492844555
Evolus, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 26 2021 | EOLS | Evolus, Inc. | Malik Vikram | Director | Grant | A | 0.00 | 18,011 | 0 | 53,724 | 35.7 K to 53.7 K (+50.43 %) |
Mar 26 2021 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Grant | A | 0.00 | 48,853 | 0 | 489,280 | 440.4 K to 489.3 K (+11.09 %) |
Mar 01 2021 | EOLS | Evolus, Inc. | Muilenburg Crystal | Chief Marketing Off ... | Option Exercise | A | 11.50 | 20,000 | 230,000 | 20,000 | |
Feb 12 2021 | EOLS | Evolus, Inc. | BLANK SIMONE | Director | Grant | A | 0.00 | 19,313 | 0 | 19,313 | 0 to 19.3 K |
Feb 09 2021 | EOLS | Evolus, Inc. | Malik Vikram | Director | Grant | A | 0.00 | 19,313 | 0 | 35,713 | 16.4 K to 35.7 K (+117.76 %) |
Feb 09 2021 | EOLS | Evolus, Inc. | HAYMAN ROBERT | Director | Grant | A | 0.00 | 19,313 | 0 | 19,313 | 0 to 19.3 K |
Feb 09 2021 | EOLS | Evolus, Inc. | GILL DAVID N | Director | Grant | A | 0.00 | 19,313 | 0 | 24,313 | 5 K to 24.3 K (+386.26 %) |
Feb 09 2021 | EOLS | Evolus, Inc. | FARRELL PETER C | Director | Grant | A | 0.00 | 19,313 | 0 | 19,313 | 0 to 19.3 K |
Feb 09 2021 | EOLS | Evolus, Inc. | Parschauer Karah Herdman | Director | Grant | A | 0.00 | 19,313 | 0 | 19,313 | 0 to 19.3 K |
Feb 01 2021 | EOLS | Evolus, Inc. | Jafar Michael M. | See Remarks | Grant | A | 0.00 | 45,000 | 0 | 219,851 | 174.9 K to 219.9 K (+25.74 %) |
Feb 01 2021 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 90,000 | 0 | 180,689 | 90.7 K to 180.7 K (+99.24 %) |
Feb 01 2021 | EOLS | Evolus, Inc. | Avelar Rui | See Remarks | Grant | A | 0.00 | 90,000 | 0 | 224,103 | 134.1 K to 224.1 K (+67.11 %) |
Feb 01 2021 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks | Grant | A | 0.00 | 266,667 | 0 | 440,427 | 173.8 K to 440.4 K (+153.47 %) |
Jan 26 2021 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Sell | S | 7.46 | 2,699 | 20,135 | 90,689 | 93.4 K to 90.7 K (-2.89 %) |
Jan 26 2021 | EOLS | Evolus, Inc. | Jafar Michael M. | See Remarks | Sell | S | 7.46 | 2,699 | 20,135 | 174,851 | 177.6 K to 174.9 K (-1.52 %) |